MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
ABEO Abeona Therapeutics
- 5.7000
- +0.0700+1.24%
Close Dec 20 16:00 ET
- 5.7000
- 0.00000.00%
Post 16:13 ET
247.78MMarket Cap-2.78P/E (TTM)
5.7900High5.5600Low210.37KVolume5.6400Open5.6300Pre Close1.20MTurnover0.74%Turnover RatioLossP/E (Static)43.47MShares9.010052wk High5.41P/B162.88MFloat Cap3.050052wk Low--Dividend TTM28.58MShs Float171874.8797Historical High--Div YieldTTM4.09%Amplitude2.1900Historical Low5.7100Avg Price1Lot Size
About Abeona Therapeutics Company
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.
Company Profile
SymbolABEO
Company NameAbeona Therapeutics
Listing DateDec 19, 2014
Issue Price0.10
Founded1974
CEOMr. Vishwas Seshadri
MarketNASDAQ
Employees84
Fiscal Year Ends12-31
Address6555 Carnegie Avenue,4th floor
CityCleveland
ProvinceOhio
CountryUnited States of America
Zip Code44103
Phone1-646-813-4701
Company Executives
- Name
- Position
- Salary
- Vishwas Seshadri
- President, Chief Executive Officer and Director
- 2.85M
- Joseph W. Vazzano, C.P.A.
- Chief Financial Officer and Chief Accounting Officer
- 1.49M
- Michael Amoroso
- Chairman of the Board
- 351.14K
- Christine Berni Silverstein
- Independent Director
- 324.89K
- Mark J. Alvino
- Independent Director
- 336.14K
- Dr. Bernhardt G. Zeiher, F.A.C.P.,F.C.C.P.,M.D.
- Independent Director
- --
- Faith L. Charles
- Independent Director
- 336.14K
- Dr. Eric Crombez, M.D.
- Independent Director
- --
- Donald A. Wuchterl
- Independent Director
- 330.52K
- Dr. Leila Alland, M.D.
- Independent Director
- 336.14K
- Brendan M. O'Malley, J.D.,PhD
- General Counsel
- 1.17M
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.